Literature DB >> 26153993

Gene therapy 'cure' for blindness wanes.

Anna Azvolinsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26153993     DOI: 10.1038/nbt0715-678

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Improvement and decline in vision with gene therapy in childhood blindness.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Alejandro J Roman; Alexander Sumaroka; Sharon B Schwartz; Elise Heon; William W Hauswirth
Journal:  N Engl J Med       Date:  2015-05-03       Impact factor: 91.245

2.  Amgen's angiopoietin blocker fails in ovarian cancer.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

3.  $1-million price tag set for Glybera gene therapy.

Authors:  Chris Morrison
Journal:  Nat Biotechnol       Date:  2015-03       Impact factor: 54.908

4.  Long-term effect of gene therapy on Leber's congenital amaurosis.

Authors:  James W B Bainbridge; Manjit S Mehat; Venki Sundaram; Scott J Robbie; Susie E Barker; Caterina Ripamonti; Anastasios Georgiadis; Freya M Mowat; Stuart G Beattie; Peter J Gardner; Kecia L Feathers; Vy A Luong; Suzanne Yzer; Kamaljit Balaggan; Ananth Viswanathan; Thomy J L de Ravel; Ingele Casteels; Graham E Holder; Nick Tyler; Fred W Fitzke; Richard G Weleber; Marko Nardini; Anthony T Moore; Debra A Thompson; Simon M Petersen-Jones; Michel Michaelides; L Ingeborgh van den Born; Andrew Stockman; Alexander J Smith; Gary Rubin; Robin R Ali
Journal:  N Engl J Med       Date:  2015-05-04       Impact factor: 91.245

  4 in total
  3 in total

1.  After Glybera's withdrawal, what's next for gene therapy?

Authors:  Melanie Senior
Journal:  Nat Biotechnol       Date:  2017-06-07       Impact factor: 54.908

2.  First AAV gene therapy poised for landmark approval.

Authors:  Eric Smalley
Journal:  Nat Biotechnol       Date:  2017-11-09       Impact factor: 54.908

3.  Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A.

Authors:  Renske M T Ten Ham; Sikon M Walker; Marta O Soares; Geert W J Frederix; Frank W G Leebeek; Kathelijn Fischer; Michiel Coppens; Stephen J Palmer
Journal:  Hemasphere       Date:  2022-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.